Skip to main content

Table 8 Possible regimen changes in the ACCG scenario.

From: Cost-effectiveness analysis of guidelines for antihypertensive care in Finland

Initial drug

1st additional drug

2nd additional drug

thiazide diuretic

ACE inhibitor (or angiotensin II subtype 1 receptor antagonist)

calcium channel blocker or beta blocker

thiazide diuretic

beta blocker

ACE inhibitor (or angiotensin II subtype 1 receptor antagonist) or calcium channel blocker

calcium channel blocker (dihydropyridine derivatives)

ACE inhibitor (or angiotensin II subtype 1 receptor antagonist)

thiazide diuretic or beta blocker

calcium channel blocker

beta blocker

ACE inhibitor (or angiotensin II subtype 1 receptor antagonist) or thiazide diuretic

ACE inhibitor (or angiotensin II subtype 1 receptor antagonist)

thiazide diuretic

calcium channel blocker or beta blocker

ACE inhibitor (or angiotensin II subtype 1 receptor antagonist)

calcium channel blocker

thiazide diuretic or beta blocker

beta blocker

thiazide diuretic

ACE inhibitor (or angiotensin II subtype 1 receptor antagonist) or calcium channel blocker

beta blocker

calcium channel blocker

ACE inhibitor (or angiotensin II subtype 1 receptor antagonist) or thiazide diuretic